Mike Collins, PhD (he/him/his)

Senior Scientist
Foghorn Therapeutics

I am a senior scientist in the Translational Medicine group at Foghorn Therapeutics, where I mainly work to support our clinical assets FHD-609 and FHD-286. I previously worked in the oncology pharmacology group at Astrazeneca Pharmaceuticals and in a molecular pathology lab at Brigham and Women's Hospital. I obtained my PhD in Cell, Molecular and Developmental Biology from Tufts University.
I currently live in Medford, MA with my wife Kelly, daughter Hannah and cat Luna.

Poster(s):

• (P 187) PRECLINICAL VALIDATION OF TARGET ENGAGEMENT ASSAYS AND INVESTIGATION OF MECHANISTIC IMPACTS OF FHD-609, A CLINICAL-STAGE BRD9 DEGRADER BEING DEVELOPED FOR THE TREATMENT OF SYNOVIAL SARCOMA